MIa is currently working to provide elesclomol-copper treatments worldwide for the clinical teams of Menkes patients who obtain authorizations for exceptional treatments at their hospitals and national medicines agencies. There are currently 3 cases ongoing in Spain, and several new cases about to start.
Menkes Children’s Exceptional Elesclomol-Copper Treatment Core Team
CORE is the functional structure of Menkes International that coordinates exceptional treatments for Menkes disease under the leadership of Dr Francesc Palau, Physician and Researcher at the Sant Joan de Déu Children’s Hospital in Barcelona. The members are as follows:
Dr. Francesc Palau (Coordinator)
Pediatrician and Clinical Geneticist, Head Dept. of Genetic Medicine, Hospital Sant Joan de Déu, and NeuroGene Senior Investigator, SJD Research Institute and CIBERER.
Dr. Elena Godoy
Pediatrician, Clinical advisor, Pediatric Complex Chronic patient and Palliative care unit, Regional University Hospital of Malaga, Biomedical Research Institute of Málaga.
Ms. Rosa Marques
Neurological Pediatric Physiotherapist and Trainer Head of Clinical Pediatric Physiotherapist Teams
Dr. Stepahie Lotz (Secretariat)
Clinical Investigator, Neurogenetics & Molecular Medicine Research Group (NeuroGene), Sant Joan de Déu Research Institute
Ms Aurora Mateos
Menkes International Executive Secretary